Průběžná roční a bezpečnostní zpráva o průběhu klinického hodnocení Disulfiram Česká republika (Identifikační znak klinického hodnocení: sukls438883/2018)

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Title in English	Disulfiram Interim annual and safety report on the course of the clinical trial Czech Republic (Identification mark of the clinical trial: sukls438883 / 2018)
Authors	DEMLOVÁ Regina BENDOVÁ Michaela
Year of publication	2021
MU Faculty or unit	Faculty of Medicine
Web	DISULFIRAM
Description	"EFFECT OF DISULFIRAM AND COPPER TREATMENT IN PATIENTS WITH METASTATIC BREAST CANCER: a prospective, open-label, single-arm phase II study." The study is accompanied by a sub-study that will obtain further data and better assess the antitumor efficacy of disulfiram and copper treatment. This substudy aims to analyze other biochemical blood parameters related to determining disulfiram levels and their concentration in the blood.
Related projects:	Český národní uzel Evropské sítě infrastruktur klinického výzkumu (CZECRIN)